Hernia Mesh Devices Market: Market Size and Market Growth (2034)
Driven by an increasing number of hernia cases, especially inguinal hernias, and advancements in surgical techniques, the demand for innovative mesh products continues to grow.
Hernia Mesh Devices Market Overview
The global hernia mesh devices market plays a crucial role in surgical repair procedures for herniasconditions in which internal organs protrude through weak spots in the abdominal wall. These devices, typically made from synthetic or biological materials, offer structural support and significantly reduce hernia recurrence rates.
Driven by an increasing number of hernia cases, especially inguinal hernias, and advancements in surgical techniques, the demand for innovative mesh products continues to grow. Surgeons and healthcare systems now prefer mesh-based repairs for their superior patient outcomes, faster recovery times, and lower complication rates compared to traditional suture-based repairs.
Market Size, CAGR, and Forecast (as per EMR Data)
According to EMR:
-
Market Size in 2023: USD 3.84 Billion
-
Projected CAGR (20242032): 3.8%
-
Forecasted Market Size by 2032: USD 5.33 Billion
This stable growth reflects the widespread adoption of hernia mesh in surgical procedures, particularly in developed markets where minimally invasive techniques are prevalent.
Market Segmentation
The hernia mesh devices market is segmented based on product type, surgery type, hernia type, and end user.
By Product Type
-
Synthetic Mesh
-
Absorbable
-
Non-Absorbable
-
-
Biological Mesh
Non-absorbable synthetic mesh is widely used due to its long-term durability and effectiveness in reinforcing weak tissues.
By Surgery Type
-
Open Repair Surgery
-
Laparoscopic Surgery
Laparoscopic surgery is gaining popularity for its minimally invasive approach, reduced scarring, and shorter hospital stays.
By Hernia Type
-
Inguinal Hernia
-
Incisional Hernia
-
Femoral Hernia
-
Umbilical Hernia
-
Others
Inguinal hernia repair dominates the segment owing to its high global prevalence, particularly among older males.
By End User
-
Hospitals
-
Ambulatory Surgical Centers
-
Others
Hospitals lead the market due to the availability of specialized infrastructure and skilled surgeons for hernia repair procedures.
For more information about this report visit
Key Growth Drivers
Rising Global Incidence of Hernia
An aging population, increasing obesity rates, and physically demanding lifestyles contribute to the rising incidence of abdominal hernias globally.
Preference for Mesh-Based Repairs
Mesh repairs offer better long-term outcomes, lower recurrence rates, and are now recommended in clinical guidelines, especially for inguinal and incisional hernias.
Advancements in Surgical Techniques
Minimally invasive techniques like laparoscopic and robotic-assisted surgeries are enhancing precision, recovery time, and demand for specialized mesh devices.
Government Initiatives and Healthcare Spending
Supportive government policies and increased healthcare budgets are driving the accessibility of advanced surgical products like hernia mesh in developing regions.
Technological Innovation in Mesh Materials
The development of lightweight, dual-layered, and absorbable meshes offers improved biocompatibility, reducing complications like mesh migration or infection.
Market Challenges
Complications Related to Mesh Use
Mesh implantation, while generally safe, may lead to complications like chronic pain, infection, or mesh rejection, prompting increased scrutiny and litigation.
Regulatory Hurdles
Hernia mesh devices must comply with strict safety and efficacy standards. Regulatory delays can impact product launches and market penetration.
High Cost of Advanced Mesh Products
Innovative mesh types, especially biological ones, tend to be expensive, limiting their adoption in low- and middle-income countries.
Product Recalls and Litigation
Numerous recalls over the years due to product defects or post-surgical complications have created trust issues among consumers and healthcare providers.
Top Companies (Key Players)
As per EMR, the major players in the hernia mesh devices market include:
-
W. L. Gore & Associates, Inc.
-
Hernia Mesh S.R.L.
-
Cousin Biotech
-
LifeCell Corporation
-
Becton, Dickinson and Company
-
B. Braun Melsungen AG
-
Medical Devices Business Services, Inc.
-
Baxter International Inc.
-
Atrium Medical Corporation (Getinge AB)
-
TELA Bio, Inc.
These companies focus on continuous innovation, new product launches, and expanding surgical partnerships to strengthen their market presence. Many are also investing in bioengineered meshes to enhance patient outcomes.
Recent Developments
-
Product Innovations: Companies like TELA Bio are developing advanced tissue-reinforcement solutions using reinforced bioscaffold technology.
-
Strategic Collaborations: Mergers and partnerships are increasing, especially between mesh manufacturers and robotic surgery technology providers.
-
Focus on Biocompatibility: Manufacturers are focusing on next-gen mesh with reduced immunogenic response and improved absorption profiles.
-
Geographic Expansion: Leading players are targeting emerging economies in Asia-Pacific and Latin America for growth, owing to increasing surgical volumes and healthcare reforms.
FAQs for SEO (Answer-Focused for Featured Snippets)
What is the current size of the hernia mesh devices market?
As of 2023, the global hernia mesh devices market was valued at USD 3.84 billion, according to EMR.
What is the expected growth rate of the hernia mesh devices market?
The market is projected to grow at a CAGR of 3.8% between 2024 and 2032, reaching USD 5.33 billion by 2032.
What are the main types of hernia mesh devices?
The market includes synthetic (absorbable and non-absorbable) and biological mesh products, with synthetic mesh being the most commonly used.
Which type of surgery dominates the hernia mesh devices market?
Laparoscopic surgery is gaining dominance due to its minimally invasive nature, although open repair surgery still holds a significant share.
Who are the top players in the hernia mesh market?
Key players include W. L. Gore & Associates, Becton, Dickinson and Company, Baxter, B. Braun, and TELE Bio, among others.
Find More Report:
